Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 1, 2019 Off

Tetra Discovery Partners Initiates Phase 2 Clinical Trial of BPN14770 in Patients with Early Alzheimer’s Disease

By BusinessWire

— Trial to evaluate effects of selective inhibitor of phosphodiesterase-4D on memory and cognitive measures — GRAND RAPIDS, Mich.–(BUSINESS WIRE)–Tetra…

May 1, 2019 Off

Alnylam Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Period Activity

By BusinessWire

− Achieved First Quarter 2019 ONPATTRO® Global Net Product Revenues of $26.3 Million with Over 400 Patients on Commercial Product…

May 1, 2019 Off

Sunovion to Present Data on LONHALA® MAGNAIR® Inhalation Solution and COPD at the American Thoracic Society International Conference 2019

By BusinessWire

– Post hoc analyses of LONHALA MAGNAIR evaluated lung function in patients with common COPD comorbidities – MARLBOROUGH, Mass.–(BUSINESS WIRE)–Sunovion…

May 1, 2019 Off

Repare Therapeutics Appoints Dr. Maria Koehler as Chief Medical Officer, Katina Dorton as Chief Financial Officer and Carol Schafer to its Board of Directors

By BusinessWire

CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics, a precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific…

May 1, 2019 Off

IVERIC bio to Report First Quarter 2019 Financial Results and Host Conference Call on Wednesday, May 8, 2019

By BusinessWire

NEW YORK–(BUSINESS WIRE)–IVERIC bio (Nasdaq:ISEE) today announced that it will report its first quarter 2019 financial and operating results on…

May 1, 2019 Off

Brink Biologics Announces Research License Agreement with Worcester Polytechnic Institute for Use of NantKwest’s NK-92® Cells

By BusinessWire

NK-92® Cell Based Bioanalytical Solutions are the Key to Optimizing R&D and Commercial Product Development Efforts for Monoclonal Antibodies, Bi-Specifics…

May 1, 2019 Off

Aimmune Therapeutics to Host Conference Call and Webcast to Discuss First Quarter 2019 Financial Results and Recent Operational Highlights

By BusinessWire

BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that it…

May 1, 2019 Off

Walgreens Forms Unique Collaboration with National Council for Behavioral Health and American Pharmacists Association to Offer Mental Health First Aid Training for Pharmacists and Team Members

By BusinessWire

Specialized training to become available for pharmacists industry-wide through Walgreens commitment to workplace wellness and the health and well-being of…

May 1, 2019 Off

Rainier Therapeutics Announces Appointment of Gary Christianson as Chief Technical Officer

By BusinessWire

SAN LEANDRO, Calif.–(BUSINESS WIRE)–Rainier Therapeutics, Inc., a privately held clinical stage drug development company, today announced the appointment of Gary…

May 1, 2019 Off

Syros Reports First Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

By BusinessWire

Successfully Completed $70 Million Financing On Track for Multiple Data Readouts for Clinical-Stage Programs in 2019 and 2020 Management to…

Posts pagination

Previous 1 … 3,237 3,238 3,239 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine